Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

NCT05082415 · clinicaltrials.gov ↗

COMPLETED

Status

9456

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Macular Degeneration (AMD)

Interventions

DRUG: Brolucizumab

Sponsor

Novartis Pharmaceuticals